This was first described in 2017 by Heitkötter et al., who analysed 779 sarcoma samples and reported strong neovascular PSMA expression in various sarcoma entities, such as pleomorphic rhabdomyosarcoma (40% of samples) and synovial sarcoma (38% of samples) [10]. The gene discussed is FOLH1; the disease is sarcoma.